News
Goldman Sachs led in advisory value with $23.8bn in transactions, while PwC topped in deal volume with 52 transactions.
Artificial intelligence, robotics and the Internet of Things (IoT) are no longer futuristic concepts—they are reshaping how consumer brands operate, engage and grow. As these technologies move from ...
BEIJING (Reuters) -Chinese state firm employee Zhang Jinming makes up for a 24% cut to his salary by delivering food for ...
Experian (EXPN), Barratt Redrow (BTRW), B&M European Value (BME), GlobalData (DATA), Robert Walters (RWA), Mobico (MCG), ...
21h
Clinical Trials Arena on MSNViiV’s HIV shot preferred, as activists spotlight funding crisis at IAS 2025ViiV's Cabenuva is administered every two months and was offered to HIV patients who achieved viral suppression from daily treatments.
20h
Medical Device Network on MSNMedtronic’s Hugo robot wins CE mark for vessel-sealing technologyMedtronic has secured EU CE mark approval for LigaSure RAS, a vessel-sealing instrument for use with the company’s Hugo robotic-assisted surgery (RAS) system.
23h
GlobalData on MSNCaranx Medical’s AI TAVI-TAVR software gains FDA approvalThe US Food and Drug Administration (FDA) has cleared Caranx Medical’s TAVIPILOT Soft, an artificial intelligence (AI)-based guide software for use during Transcatheter Aortic Valve Implantation (TAVI ...
5d
Pharmaceutical Technology on MSNCTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031The US dominates overall sales, yet GlobalData predicts that China is shaping up to be a formidable presence in the cell therapy space.
Both AstraZeneca and MSD have tied lucrative licensing deals for two of LaNova’s oncology assets in recent years.
1d
Retail Banker International on MSNJP Morgan, Houlihan Lokey lead North American M&A advisers in H1 2025JP Morgan and Houlihan Lokey have led the mergers and acquisitions (M&A) rankings for financial advisers in North America for ...
4d
GlobalData on MSNNvidia’s historic $4 trillion market cap highlights AI chip sectorAccording to GlobalData’s Innovation Radar report, “AI Chips – Trends, Market Dynamics and Innovations,” the global AI chip ...
5d
GlobalData on MSNPfizer and Astellas’ Xtandi improves OS as combination therapyPfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results